Immunosuppressants - PDFSEARCH.IO - Document Search Engine

Immunosuppressants
Results: 1821

#	Item
281	Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome A stakeholder meeting was held on 24 June 2014 to discuss the Pharmaceutical Benefi Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2015-03-12 23:53:04 Organ failure Immunosuppressants Eculizumab Kidney diseases Hemolytic-uremic syndrome Chronic kidney disease Dialysis Pharmaceutical Benefits Scheme Kidney transplantation Medicine Health Nephrology
282	Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome A stakeholder meeting was held on 24 June 2014 to discuss the Pharmaceutical Benefit Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2015-03-12 23:53:04 Organ failure Immunosuppressants Eculizumab Kidney diseases Hemolytic-uremic syndrome Chronic kidney disease Dialysis Pharmaceutical Benefits Scheme Kidney transplantation Medicine Health Nephrology
283	SCHEDULE OF PHARMACEUTICAL BENEFITS EFFECTIVE 1 FEBRUARY 2015 ERRATA (1) This Erratum corrects the entry for Olanzapine in the 1 February 2015 Schedule. The following Note should appear in the Schedule entry for all Olan Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2015-01-26 18:49:49 Connective tissue diseases Rheumatology Immunosuppressants Pharmacology Tocilizumab Rheumatoid arthritis Nurse practitioner Juvenile idiopathic arthritis Nursing Health Medicine Arthritis
284	SCHEDULE OF PHARMACEUTICAL BENEFITS EFFECTIVE 1 NOVEMBER 2014 ERRATA (1) This Erratum corrects the entry for Olanzapine in the 1 November 2014 Schedule. The following Note should appear in the Schedule entry for all Olan Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2014-10-20 19:50:21 Connective tissue diseases Rheumatology Immunosuppressants Pharmacology Tocilizumab Rheumatoid arthritis Juvenile idiopathic arthritis Nurse practitioner Nursing Health Medicine Arthritis
285	SCHEDULE OF PHARMACEUTICAL BENEFITS EFFECTIVE 1 OCTOBER 2014 ERRATA (1) This Erratum corrects the entry for Olanzapine in the 1 October 2014 Schedule. The following Note should appear in the Schedule entry for all Olanza Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2014-10-02 00:13:48 Connective tissue diseases Rheumatology Immunosuppressants Pharmacology Tocilizumab Rheumatoid arthritis Nurse practitioner Juvenile idiopathic arthritis Nursing Health Medicine Arthritis
286	Million man study examines long-term effects of blocking inflammation Add to Reading List Source URL: medicalxpress.com Language: English - Date: 2015-04-16 23:29:28 Rheumatology Autoimmune diseases Arthritis Cytokines Anakinra Immunosuppressants Rheumatoid arthritis Cardiovascular disease Interleukin Medicine Health Anatomy
287	ACTEMRA® pronounced (Act-tem-ra) contains the active ingredient tocilizumab (rch) Consumer Medicine Information Add to Reading List Source URL: gp2u.com.au Language: English - Date: 2013-08-31 02:43:59 Rheumatoid arthritis Anakinra Health Medicine Immunosuppressants Anatomy Tocilizumab
288	Hindawi Publishing Corporation Case Reports in Hematology Volume 2015, Article ID[removed], 4 pages http://dx.doi.org[removed][removed]Case Report Add to Reading List Source URL: downloads.hindawi.com Language: English - Date: 2015-01-29 07:03:06 Acquired hemolytic anemia Stem cells Eculizumab Immunosuppressants Thrombotic microangiopathy Hematopoietic stem cell transplantation Graft-versus-host disease Hemolytic-uremic syndrome Organ transplantation Medicine Health Transplantation medicine
289	Hindawi Publishing Corporation BioMed Research International Volume 2015, Article ID[removed], 3 pages http://dx.doi.org[removed][removed]Editorial Add to Reading List Source URL: downloads.hindawi.com Language: English - Date: 2015-03-12 03:23:07 Pharmacology Arthritis Connective tissue diseases Rheumatology Monoclonal antibodies Rheumatoid arthritis Adalimumab Etanercept Cardiovascular disease Medicine Health Immunosuppressants
290	Blackwell Lab Rapamycin Plates Protocol Add to Reading List Source URL: blackwellweb.joslin.harvard.edu Language: English - Date: 2014-02-19 14:04:44 Macrolides Biochemistry Lactams Sirolimus Mammalian target of rapamycin Dimethyl sulfoxide Chemistry Biology Immunosuppressants

UPDATE